Invention Grant
- Patent Title: Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
- Patent Title (中): 融合三唑用于治疗或预防轻度认知障碍
-
Application No.: US13819239Application Date: 2011-09-01
-
Publication No.: US08901309B2Publication Date: 2014-12-02
- Inventor: Tatsuki Koike , Minoru Nakamura , Takafumi Takai , Yuichi Kajita , Makoto Kamata
- Applicant: Tatsuki Koike , Minoru Nakamura , Takafumi Takai , Yuichi Kajita , Makoto Kamata
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2010-197064 20100902; JP2011-143548 20110628
- International Application: PCT/JP2011/070419 WO 20110901
- International Announcement: WO2012/029991 WO 20120308
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
The present invention provides a heterocycle derivative having a superior amyloid β production inhibitory activity and/or a superior γ-secretase modulation activity, and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.
Public/Granted literature
- US20130178497A1 FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT Public/Granted day:2013-07-11
Information query
